Endpoints News

mRNA biotech targets muscular dystrophy		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T Wed Th F

17 June, 2026

Biopharma has metabolized the tariff chaos, but the ground keeps shifting under manufacturing and supply chain teams. Hear directly from the experts on what’s changed, what’s working, and what to watch. Join us.

SPOTLIGHT

Endpoints Women in Biopharma: Nominate for 2026

Six leaders working on LGBTQ+ inclusion in biopharma

news

Jazz turns to AbCellera for T cell engagers in GI cancers in up to $4.1B partnership

Exclusive: Spot Bio launches with $40M to study mRNA therapy for muscular dystrophy

Triveni Bio raises $65M ahead of upcoming readouts on eczema drugs

Migraine biotech makes its debut with $46M to advance preclinical pipeline

B cell therapy maker Be Bio stops hemophilia trial

A year ago, biotech was in its bleakest stretch in a decade. Now IPOs are rebounding and China deals are heating up. John Carroll and a panel of industry leaders dig into the latest Endpoints 100 results and uncover what’s next for the sector.

in case you missed it

FDA raises efficacy questions for Moderna’s flu vaccine but no dire flags

Health groups say HHS is trying to 'rush reinstatement' of ACIP

FDA greenlights Colorado's drug import proposal

News Briefing

Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill

Exclusive: UCSF spinout nets $9.1M to test virus therapy for brain cancer in China

Edgewise to advance heart drug into Phase 3 following mid-stage data update

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

Hacking group claims major hack of Novo Nordisk and attempted $25 million extortion

After several years focusing on its internal pipeline, AbCellera is back to forging partnerships — its latest is with Jazz Pharmaceuticals on preclinical T cell engagers for certain cancers. You can read more from Kyle LaHucik here.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com

Endpoints Studio
Endpoints Webinars

Endpoints Events
Biopharma Jobs

Worldwide made. Thanks for reading.